MOgene

Executive Summary

MOgene is a US-based genomic services company founded in 2004 and headquartered in St. Louis, Missouri. The company provides comprehensive, customized, and data-driven genomic sequencing and analysis services to the biopharma, agriculture (agritech), and diagnostics sectors. By positioning itself as a consultative, one-stop solution, MOgene leverages over two decades of experience to deliver research and clinical insights. Its focus on high-quality, scalable genomic solutions caters to the growing demand for precision medicine, agricultural genomics, and diagnostic innovation. As a private entity with a established track record, MOgene is well-placed to capitalize on the expanding genomics market, though it faces competition from larger service providers and in-house sequencing capabilities of major biopharma firms.

Upcoming Catalysts (preview)

• Q2 2026Expansion of Agricultural Genomic Services via Strategic Partnerships70% success
• Q4 2026Launch of Next-Generation Sequencing Platform for Clinical Diagnostics60% success
• TBDFDA Clearance of Proprietary Liquid Biopsy Assay30% success